QUALITY BY DESIGN-GUIDED WHITE AND GREEN HPLC METHOD FOR THE DETERMINATION OF PROCESS-RELATED IMPURITIES OF ELACESTRANT IN BULK DRUG AND PHARMACEUTICAL FORMULATIONS

Authors

  • VENKATA SAI SURESH KUMAR SISTA Department of Chemistry, Institute of Science, GITAM University, Visakhapatnam-530045, (Andhra Pradesh), India https://orcid.org/0009-0007-2713-7786
  • ANJALI JHA Department of Chemistry, Institute of Science, GITAM University, Visakhapatnam-530045, (Andhra Pradesh), India https://orcid.org/0000-0003-1681-1660
  • VLNSH HARI HARAN A. Department of Chemistry, Institute of Science, GITAM University, Visakhapatnam-530045, (Andhra Pradesh), India https://orcid.org/0000-0003-3360-1198

DOI:

https://doi.org/10.22159/ijap.2026v18i2.56991

Keywords:

Elacestrant, Process-related impurities, Green analytical method, QbD approach, RGB profile

Abstract

Objective: The quality by design (QbD) guided, robust, and environmentally sustainable HPLC method was developed for the simultaneous quantification of elacestrant and its process-related impurities.

Methods: The method optimisation uses organic solvent composition, mobile phase pH, and flow rate as critical method parameters. Based on structural features and pKa values of the analytes, separation was achieved on a hypersilgold C18 (250×4.6 mm, 5 µm) column using a green mobile phase of ethanol and 0.1% aqueous formic acid (65:35, v/v) at pH 3.4 at a 0.7 ml/min flow rate, achieving baseline resolution between elacestrant and its close eluting dihydrochloride impurity ( = 3.1) with good symmetry (tailing factor ~1.1) and a total run time of 13 min.

Results: The method validation demonstrates excellent linearity (r²>0.999), accuracy (recoveries 99–101%), precision (RSD<1.5%), and sensitivity (LOQs 0.1–0.2 µg/ml for impurities). The sustainability assessment confirms the strong environmental and operational profile of the method. The AGREE evaluation yields a score of 0.78, whereas the GAPI pictogram displays predominantly green fields, confirming the strong alignment of the proposed method with green analytical chemistry principles. Further, the RGB12 model demonstrates favourable scores of 73.2% (redness), 75.8% (greenness), and 86.7% (blueness) with an integrated whiteness score of 78.3%. These results classify the proposed method as a white analytical procedure.

Conclusion: Collectively, these outcomes confirm that the developed method was not only analytically reliable but also environmentally responsible and economically feasible. Hence, the method was highly suitable for routine impurity profiling and sustainable quality control of elacestrant in pharmaceutical formulations.

References

1. Valenza C, Trapani D, Bidard FC, Gligorov J, Cortes J, Turner N. Elacestrant in ESR1-mutant endocrine-responsive metastatic breast cancer: should health authorities consider post hoc data to inform priority access? ESMO Open. 2024;9(9):103701. doi: 10.1016/j.esmoop.2024.103701, PMID 39232441.

2. Lloyd MR, Wander SA, Hamilton E, Razavi P, Bardia A. Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role. Ther Adv Med Oncol. 2022;14:17588359221113694. doi: 10.1177/17588359221113694, PMID 35923930.

3. Bihani T, Patel HK, Arlt H, Tao N, Jiang H, Brown JL. Elacestrant (RAD1901), a selective estrogen receptor degrader (SERD), has antitumor activity in multiple ER+ breast cancer patient-derived xenograft models. Clin Cancer Res. 2017;23(16):4793-804. doi: 10.1158/1078-0432.CCR-16-2561, PMID 28473534.

4. Garner F, Shomali M, Paquin D, Lyttle CR, Hattersley G. RAD1901: a novel orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models. Anti-Cancer Drugs. 2015;26(9):948-56. doi: 10.1097/cad.0000000000000271, PMID 26164151.

5. Lakshmana Prabu S, Suriyaprakash TN. Impurities and its importance in pharmacy. Int J Pharm Sci Rev Res. 2010;3(2):66-71.

6. ICH Guideline Q3C (R5) guideline for residual solvents impurities. EMA/CHMP/ICH/82260/2006; 2011.

7. Nanda BP, Rani P, Bhatia R. Unexplored drug combinations for analytical method development by HPLC. J Chromatogr Open. 2024;5:100123. doi: 10.1016/j.jcoa.2024.100123.

8. Ravinder B, Hemant KT, Vijay Srinivas P, Likhitha A, Sambasiva Rao T, Naveena G. Analytical quality by design approach in RP-HPLC method development for the quantification of mirabegron and solifenacin succinate in pharmaceutical formulation. Lett Appl Nanobiosci. 2024;14(1):1-12. doi: 10.33263/lIANBS141.048.

9. Wu J, Yu H, Cao N, Zhang J, Khan J, lee D. Ecological footprint analysis as a tool for advancing sustainable development goals (SDGs): evidence from China. Ecol Indic. 2025;176:113653. doi: 10.1016/j.ecolind.2025.113653.

10. Cahide TEL-Inci Kazkayasi Gokçen TELLI B. Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the aav-mediated over-expression model of parkinson’s disease: a time-course study. JRP. 2021;25(3):352-8. doi: 10.29228/jrp.25.

11. Prasad SS, Kasimala BB, Anna VR. QbD based analytical method development and validation for the separation and quantification of agomelatine and its impurities in solid oral dosage forms using HPLC. RJC. 2021;14(4):2183-90. doi: 10.31788/RJC.2021.1446426.

12. Saini S, Kaur R, Kaur R, Gulati M, Singh B, Hussain A. QbD and green metric based HPLC method development and validation of bromocriptine mesylate in bulk product and biological samples. J Chromatogr B. 2025;1258:124566. doi: 10.1016/j.jchromb.2025.124566.

13. Subhashini K, Giri Prasad G, Rudraraju Ramesh R, Musunuri S. Quantitative analysis of Elacestrantin pharmaceutical dosage forms by ultra-performance liquid chromatography-mass spectrometry with emphasis on stability assessment. Asian J Pharm Clin Res. 2025;18(7):185-97. doi: 10.22159/ajpcr.2025v18i7.54496.

14. Tummala SR, Amgoth KP. Development of GC-MS/MS method for simultaneous estimation of four nitrosoamine genotoxic impurities in valsartan. Turk J Pharm Sci. 2022;19(4):455-61. doi: 10.4274/tjps.galenos.2021.17702, PMID 36047600.

15. Bhupatiraju RV, Peddi P, Edla S, Rekha K, Kasimala BB. Green analytical approach for HPLC method development for quantification of sorafenib and its pharmacopeia impurities: LC–MS/MS characterization and toxicity prediction of stress degradation products. Sep Sci Plus. 2024;7(9):e202400106. doi: 10.1002/sscp.202400106.

16. Veerendra YV, Brahman PK, Mankumare SD, Ch J, C VK. Evaluation of analytical greenness metric for an eco-friendly method developed through the integration of green chemistry and quality-by-design for the simultaneous determination of nebivolol hydrochloride telmisartan valsartan and amlodipine besylate. Heliyon. 2024;10(16):e35376. doi: 10.1016/j.heliyon.2024.e35376, PMID 39220975.

17. Nowak PM, Wietecha Posluszny R, Pawliszyn J. White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality. TrAC Trends Anal Chem. 2021;138:116223. doi: 10.1016/j.trac.2021.116223.

18. Charyulu KV, Charyulu RN, Chandran SP, Patil P, Jose J. Quality by design (QBD) approach for optimization of mangiferin-loaded nanoparticles for the safe and effective treatment of breast cancer. Int J Appl Pharm. 2025;17(5):146-58. doi: 10.22159/ijap.2025v17i5.54215.

19. Yalla K, Pawar AK, Manda K. A greenness evaluated bioanalytical method for quantification of sparsentan in rat plasma and its application to pharmacokinetic studies by LC-MS. Int J Appl Pharm. 2025;17(5):168-80. doi: 10.22159/ijap.2025v17i5.54341.

Published

07-03-2026

How to Cite

KUMAR SISTA, V. S. S., JHA, A., & HARAN A., V. H. (2026). QUALITY BY DESIGN-GUIDED WHITE AND GREEN HPLC METHOD FOR THE DETERMINATION OF PROCESS-RELATED IMPURITIES OF ELACESTRANT IN BULK DRUG AND PHARMACEUTICAL FORMULATIONS. International Journal of Applied Pharmaceutics, 18(2), 484–493. https://doi.org/10.22159/ijap.2026v18i2.56991

Issue

Section

Original Article(s)

Similar Articles

<< < 130 131 132 133 134 > >> 

You may also start an advanced similarity search for this article.